These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Production of anti-SARS-CoV-2 hyperimmune globulin from convalescent plasma. Vandeberg P; Cruz M; Diez JM; Merritt WK; Santos B; Trukawinski S; Wellhouse A; Jose M; Willis T Transfusion; 2021 Jun; 61(6):1705-1709. PubMed ID: 33715160 [TBL] [Abstract][Full Text] [Related]
25. Patients with Prolonged Positivity of SARS-CoV-2 RNA Benefit from Convalescent Plasma Therapy: A Retrospective Study. Wu Y; Hong K; Ruan L; Yang X; Zhang J; Xu J; Pan S; Ren L; Chen L; Huang C; Shang Y Virol Sin; 2020 Dec; 35(6):768-775. PubMed ID: 32865701 [TBL] [Abstract][Full Text] [Related]
26. COVID-19 Convalescent Plasma: from donation to treatment - A Systematic Review & Single Center Experience. Fabricius MM; Dandachi D Mo Med; 2021; 118(1):74-80. PubMed ID: 33551490 [TBL] [Abstract][Full Text] [Related]
27. Upper age limits for convalescent plasma donation and treatment of COVID-19 patients: A further marker of ageism. Fedecostante M; O'Neill D; Pierri F; Carrieri B; Lattanzio F; Cherubini A Transfusion; 2021 Sep; 61(9):2799-2800. PubMed ID: 34227110 [No Abstract] [Full Text] [Related]
28. Convalescent plasma from COVID 19 patients enhances intensive care unit survival rate. A preliminary report. Cantore I; Valente P Transfus Apher Sci; 2020 Oct; 59(5):102848. PubMed ID: 32888822 [No Abstract] [Full Text] [Related]
29. Convalescent Plasma Therapy for Corona Virus Disease 2019: a Long Way to Go but Worth Trying. Yoo JH J Korean Med Sci; 2020 Apr; 35(14):e150. PubMed ID: 32281318 [No Abstract] [Full Text] [Related]
30. Successful Use of COVID-19 Convalescent Plasma in a Patient Recently Treated for Follicular Lymphoma. Wright Z; Bersabe A; Eden R; Bradley J; Cap A Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):66-68. PubMed ID: 32682684 [No Abstract] [Full Text] [Related]
31. A Retrospective Study on the Effects of Convalescent Plasma Therapy in 24 Patients Diagnosed with COVID-19 Pneumonia in February and March 2020 at 2 Centers in Wuhan, China. Huang S; Shen C; Xia C; Huang X; Fu Y; Tian L Med Sci Monit; 2020 Dec; 26():e928755. PubMed ID: 33264276 [TBL] [Abstract][Full Text] [Related]
32. Convalescent Plasma Lowered Risk of Death in COVID-19 ARDS. Harris E JAMA; 2023 Nov; 330(20):1945. PubMed ID: 37938859 [No Abstract] [Full Text] [Related]
34. New generation of vaccines and convalescent plasma therapy for management of CoV-2: Perspectives from the UK and potential deployment in the current global pandemic. Seghatchian J Transfus Apher Sci; 2021 Feb; 60(1):103051. PubMed ID: 33461918 [No Abstract] [Full Text] [Related]
35. Testing an Old Therapy Against a New Disease: Convalescent Plasma for COVID-19. Rubin R JAMA; 2020 Jun; 323(21):2114-2117. PubMed ID: 32352484 [No Abstract] [Full Text] [Related]
36. Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors. Kunze KL; Johnson PW; van Helmond N; Senefeld JW; Petersen MM; Klassen SA; Wiggins CC; Klompas AM; Bruno KA; Mills JR; Theel ES; Buras MR; Golafshar MA; Sexton MA; Diaz Soto JC; Baker SE; Shepherd JRA; Verdun NC; Marks P; Paneth NS; Fairweather D; Wright RS; van Buskirk CM; Winters JL; Stubbs JR; Senese KA; Pletsch MC; Buchholtz ZA; Rea RF; Herasevich V; Whelan ER; Clayburn AJ; Larson KF; Ripoll JG; Andersen KJ; Lesser ER; Vogt MNP; Dennis JJ; Regimbal RJ; Bauer PR; Blair JE; Casadevall A; Carter RE; Joyner MJ Nat Commun; 2021 Aug; 12(1):4864. PubMed ID: 34381030 [TBL] [Abstract][Full Text] [Related]